Cargando…
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365940/ https://www.ncbi.nlm.nih.gov/pubmed/37058483 http://dx.doi.org/10.1182/bloodadvances.2023009781 |
| _version_ | 1785077061357928448 |
|---|---|
| author | Komrokji, Rami S. Aguirre, Luis E. Al Ali, Najla H. Chan, Onyee Xie, Zhuoer Kuykendall, Andrew Sweet, Kendra Lancet, Jeffrey E. Padron, Eric Sallman, David A. |
| author_facet | Komrokji, Rami S. Aguirre, Luis E. Al Ali, Najla H. Chan, Onyee Xie, Zhuoer Kuykendall, Andrew Sweet, Kendra Lancet, Jeffrey E. Padron, Eric Sallman, David A. |
| author_sort | Komrokji, Rami S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10365940 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103659402023-07-25 Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes Komrokji, Rami S. Aguirre, Luis E. Al Ali, Najla H. Chan, Onyee Xie, Zhuoer Kuykendall, Andrew Sweet, Kendra Lancet, Jeffrey E. Padron, Eric Sallman, David A. Blood Adv Research Letter The American Society of Hematology 2023-04-17 /pmc/articles/PMC10365940/ /pubmed/37058483 http://dx.doi.org/10.1182/bloodadvances.2023009781 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Komrokji, Rami S. Aguirre, Luis E. Al Ali, Najla H. Chan, Onyee Xie, Zhuoer Kuykendall, Andrew Sweet, Kendra Lancet, Jeffrey E. Padron, Eric Sallman, David A. Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes |
| title | Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes |
| title_full | Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes |
| title_fullStr | Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes |
| title_full_unstemmed | Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes |
| title_short | Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes |
| title_sort | activity of luspatercept and esas combination for treatment of anemia in lower-risk myelodysplastic syndromes |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365940/ https://www.ncbi.nlm.nih.gov/pubmed/37058483 http://dx.doi.org/10.1182/bloodadvances.2023009781 |
| work_keys_str_mv | AT komrokjiramis activityofluspaterceptandesascombinationfortreatmentofanemiainlowerriskmyelodysplasticsyndromes AT aguirreluise activityofluspaterceptandesascombinationfortreatmentofanemiainlowerriskmyelodysplasticsyndromes AT alalinajlah activityofluspaterceptandesascombinationfortreatmentofanemiainlowerriskmyelodysplasticsyndromes AT chanonyee activityofluspaterceptandesascombinationfortreatmentofanemiainlowerriskmyelodysplasticsyndromes AT xiezhuoer activityofluspaterceptandesascombinationfortreatmentofanemiainlowerriskmyelodysplasticsyndromes AT kuykendallandrew activityofluspaterceptandesascombinationfortreatmentofanemiainlowerriskmyelodysplasticsyndromes AT sweetkendra activityofluspaterceptandesascombinationfortreatmentofanemiainlowerriskmyelodysplasticsyndromes AT lancetjeffreye activityofluspaterceptandesascombinationfortreatmentofanemiainlowerriskmyelodysplasticsyndromes AT padroneric activityofluspaterceptandesascombinationfortreatmentofanemiainlowerriskmyelodysplasticsyndromes AT sallmandavida activityofluspaterceptandesascombinationfortreatmentofanemiainlowerriskmyelodysplasticsyndromes |